Differentiation of Midbrain Dopaminergic Neurons from Human Embryonic Stem Cells (hESCs)

Table of Contents

Introduction

If you are looking to generate midbrain dopaminergic (mDA) neurons from human embryonic stem cells (hPSCs), you've come to the right place. Based on the highly reproducible methodology developed by Kim and colleagues, this scalable protocol outlines the key steps to derive these specialized neurons. mDA neurons are vital for research into translational therapies and regenerative medicine with a particular relevance to the modeling and treatment of Parkinson's disease. Let's get started on successfully deriving your mDA neurons!

Materials

  • Human embryonic stem cells (e.g., WA09)
  • Basement membrane extract (BME)
  • Neurobasal medium
  • N2 supplement
  • B27 supplement
  • L-glutamine
  • SB 431542 (HB3555)
  • LDN 193189 (HB5624)
  • DAPT (HB3345)
  • CHIR 99021 (HB1261)
  • Y-27632 (HB2297)
  • Recombinant SHH
  • Recombinant BDNF (HB3485)
  • Recombinant GDNF (HB5735)
  • L-Ascorbic acid (HB1238)
  • Recombinant TGF-β3
  • Dibutyryl cAMP
  • Poly-Ornithine
  • Laminin
  • Fibronectin

Media & Buffers

Media A - Day 1

Component Concentration
Neurobasal medium supplemented with N2, B27, and L-Glutamine Base

LDN 193189 (HB5624)

250 nM
SB 431542 (HB3555) 10 μM
CHIR 99021 (HB1261) 0.7 μM
Y-27632 (HB2297) 10 μM
SHH 500 ng/ml

Media B - Days 2-3

Component Concentration
Neurobasal medium supplemented with N2, B27, and L-Glutamine Base

LDN 193189 (HB5624)

250 nM
SB 431542 (HB3555) 10 μM
CHIR 99021 (HB1261) 0.7 μM
SHH 500 ng/ml

Media C - Days 4-6

Component Concentration
Neurobasal medium supplemented with N2, B27, and L-Glutamine Base
LDN 193189 (HB5624) 250 nM
SB 431542 (HB3555) 10 μM
CHIR 99021 (HB1261) 7.5 μM
SHH 500 ng/ml

Media D - Days 7-9

Component Concentration
Neurobasal medium supplemented with N2, B27, and L-Glutamine Base
CHIR 99021 (HB1261) 7.5 μM

Media E - Days 10-12

Component Concentration
Neurobasal medium supplemented with B27 and L-Glutamine Base
Recombinant BDNF (HB3485) 20 ng/ml
Recombinant GDNF (HB5735) 20 ng/ml
L-Ascorbic acid (HB1238) 0.2 μM
Dibutyryl cAMP 500 μM
Recombinant TGF-β3 1 ng/ml
CHIR 99021 (HB1261) 3 μM

Media F - Days 12-15

Component Concentration
Neurobasal medium supplemented with B27 and L-Glutamine Base
Recombinant BDNF (HB3485) 20 ng/ml
Recombinant GDNF (HB5735) 20 ng/ml
L-Ascorbic acid (HB1238) 0.2 μM
Dibutyryl cAMP 500 μM
Recombinant TGF-β3 1 ng/ml

DAPT (HB3345)

10 μM

Media G - Day 16 onwards

Component Concentration
Neurobasal medium supplemented with B27 and L-Glutamine Base
Recombinant BDNF (HB3485) 20 ng/ml
Recombinant GDNF (HB5735) 20 ng/ml
L-Ascorbic acid (HB1238) 0.2 μM
Dibutyryl cAMP 500 μM
Recombinant TGF-β3 1 ng/ml
 

Protocol

  1. At Day 0, plate hESCs (e.g., WA09) onto culture vessels pre-coated with basement membrane extract (BME) at a density of 400,000 cells / cm2.
  2. Day 1: Culture the cells in Media A.
  3. Days 2-3: Culture the cells in Media B with daily media changes.
  4. Days 4-6: Culture the cells in Media C with daily media changes..
  5. Days 7-9: Culture the cells in Media D with daily media changes.. 
  6. Day 10: Culture the cells in Media E
  7. Day 11: Dissociate the cells and replate in Media E on polyornithine (15µg/ml), laminin (1µg/ml) and fibronectin (2µg/ml) coated dishes at a density of 800,000 cells / cm2.
  8. Days 12-15: Culture the cells in Media F with daily media changes.
  9. Day 16 onwards: Dissociate the cells and replate in Media G on polyornithine (15µg/ml), laminin (1µg/ml) and fibronetcin (2µg/ml) coated dishes at a density of 800,000 cells / cm2. Cells can be cryopreserved at this point if desired.
  10. Day 25: Dissociate the cells using accutase and replate at 200,000 - 300,000 cells / cm2 in Media G until needed for electrophysiology experiments.

References

  • Kim et al. (2021) Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use. Cell Stem Cell 28 343. PMID: 33545081